(1S,2S,5R)-3-(tert-Butoxycarbonyl)-3-azabicyclo[3.1.0]hexane-2-carboxylic acid, 95.0%, 100mg

2-(HYDROXY(4-PHENOXYPHENYL)METHYLENE)MALONONITRILE, 95.0%, 100mg

(S)-3-(4-Fluoro-2-nitrophenoxy)pyrrolidine hydrochloride, 95.0%, 1g

4-Amino-5-chloro-2-methoxy-N-(piperidin-4-ylmethyl)benzamide hydrochloride, 95.0%, 1g

2,2-Dimethyl-3,4-dihydronaphthalen-1(2H)-one, 97.0%, 5g

6-(trifluoromethyl)-1,2,3,4-tetrahydroquinazoline-2,4-dione, 98%, 100mg

GC capillary column ROTI®Cap-1701, 10 m, 0.25 mm, 0.25 µm, 1 Piece(s)

2-(Trifluoromethyl)thiazole-5-carboxylic acid, 95.0%, 50g

2-Fluoro-4-methoxybenzenesulfonyl chloride, 95.0%, 100mg

1-ethyl-5,6,7-trimethoxy-1H-indole-2-carboxylic acid, 95.0%, 2g

(4R,4'R)-2,2'-(1,3-Dihydro-2H-inden-2-ylidene)bis[4,5-dihydro-4-(phenylmethyl)oxazole], 97%, 100mg

Estradiene dione-3-keta, 95.0%, 25g

Sodium hydroxide solution 50%, extra pure, 5 l, plastic packaging.